Do generic firms and the Spanish public purchaser respond to consumer price differences of generics under reference pricing?

Health Policy

Volumn 98, Issue 2-3, 2010, Pages 186-194

  Puig Junoy, Jaume ^a   Moreno Torres, Iván ^a  

^a DEPARTMENT OF ECONOMICS AND BUSINESS   (Spain)

Author keywords

Generic drugs; Pharmaceutical expenditure; Price competition; Reference pricing

Indexed keywords

AMLODIPINE; ENALAPRIL; FLUOXETINE; GENERIC DRUG; IBUPROFEN; OMEPRAZOLE; PAROXETINE; PRAVASTATIN; SIMVASTATIN;

ARTICLE; CONSUMER; DESCRIPTIVE RESEARCH; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; HEALTH CARE; SPAIN;

CHOICE BEHAVIOR; DATABASES, FACTUAL; DRUGS, GENERIC; ECONOMIC COMPETITION; HUMANS; NATIONAL HEALTH PROGRAMS; SPAIN;

EID: 78249285572     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2010.06.016     Document Type: Article

References (10)

1. López-Casasnovas G., Puig-Junoy J. Review of the literature on reference pricing. Health Policy 2000, 54:87-123.
2. Aaserud M., Austvoll-Dahlgren A., Kösters J.P., Oxman A.D., Ramsay C., Sturm H. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (Review). The Cochrane Library 2009, 3:1-43.
3. Ioannides-Demos L., Ibrahim J.E., McNeil J.J. Reference-based pricing schemes. Effect on pharmaceutical expenditure, resource utilisation and health outcomes. Pharmacoeconomics 2002, 20:577-591.
4. Zweifel P., Crivelli L. Price regulation of drugs: lessons from Germany. Journal of Regulatory Economics 1996, 10:257-273.
5. Podnar K., Molj B., Golob U. How reference pricing for pharmaceuticals can increase generic share of market: the Slovenian experience. Journal of Public Policy and Marketing 2007, 26:89-101.
6. Pavcnik N. Do pharmaceutical prices respond to potential out-of-pocket expenses?. Rand Journal of Economics 2002, 33:469-487.
7. Kanavos P., Costa-Font J., Seeley E. Competition in off-patent drug markets. Issues, regulation and evidence. Economic Policy 2008, 23:499-544.
8. Puig-Junoy J. Incentives and pharmaceutical reimbursement reforms in Spain. Health Policy 2004, 67:149-165.
9. Antoñanzas F., Oliva J., Pinillos M., Juárez C. Economic aspects of the new Spanish laws on pharmaceutical preparations. European Journal of Health Economics 2007, 8:297-300.
10. Kanavos P., Taylor D. Pharmacy discounts on generic medicines in France: is there room for further efficiency savings?. Current Medical Research and Opinion 2007, 23:2467-2476.